Injective vs Monad
Compare Injective and Monad on TVL, fees, revenue and activity to understand how these projects stack up.
$14.8M
Injective is a Cosmos‑SDK Layer‑1 with on‑chain order books, zero‑gas trading and a frequent batch auction that mitigates MEV. Its built‑in Ethereum bridge lets users bring ERC‑20s without custodial risk, and the WasmX module supports CosmWasm smart contracts. INJ holders can stake or participate in governance that controls upgrades like the 2024 Volan hard fork which added liquid staking.
View Full Page$985.63M
Monad is an Ethereum-compatible Layer-1 focused on high throughput, low fees and scalable decentralization. Its architecture targets 10,000 TPS with sub-second finality while preserving bytecode-level EVM compatibility, so Solidity contracts, wallets and infrastructure can work without major rewrites. The MON token is tracked by CoinGecko as the network's associated asset.
View Full PageKey Metrics Comparison
Injective
TVL$14.8M
24h Volume$5.25M
24h Fees$775
24h Revenue$232
30d Fees$34.5K
30d Revenue$9K
7d TVL Change+30.16%
Dominance0.01%
Monad
TVL$985.63M
24h Volume$43.41M
24h Fees$205.1K
24h Revenue$21K
30d Fees$6.38M
30d Revenue$739.9K
7d TVL Change+0.51%
Dominance0.35%
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
TVL Share
Share of combined TVL
Injective
1.5%Monad
98.5%Volume Share
Share of combined 24h volume
Injective
10.8%Monad
89.2%Fees Share
Share of combined 24h fees
Injective
1.0%Monad
99.6%Revenue Share
Share of combined 24h revenue
Injective
1.1%Monad
98.9%7d TVL Performance
TVL change over last 7 days
Injective
30.16%Monad
0.51%Dominance
Market dominance by TVL
Injective
0.0%Monad
0.3%TVL Comparison
Injective
Monad